New Drug Approved for the Treatment of Excessive Sleepiness
Cephalon Inc, has received FDA approval to market Nuvigil, a non-amphetamine wake-promoting agent.
Read MoreCephalon Inc, has received FDA approval to market Nuvigil, a non-amphetamine wake-promoting agent.
Read MoreHigh numbers of circulating apoptotic endothelial cells may explain the endothelial dysfunction seen in patients with obstructive sleep apnea.
Read MoreA study suggests lack of sleep is a risk factor for elderly suicide.
Read MoreOne cause of aggressive or bullying behavior in schoolchildren may be an undiagnosed SRBD.
Read MoreSleep restriction may decrease heart rate variability.
Read More